Collecting data on penile cancer characteristics and outcomes
Contemporary Characteristics of Penile Carcinoma: at M.D. Anderson Cancer Center, and Harris Health System and Katy, Sugar Land, the Woodlands and Bay Area Regional Care Centers
This study is collecting information from men with penile cancer to see how the disease behaves and what treatments work best over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Sex | Male |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT04996849 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a prospective database of patients diagnosed with penile cancer, specifically focusing on squamous cell carcinoma. It will gather data on the presenting features, management strategies, and outcomes of these patients over a period of up to 15 years, with data collection occurring every six months. The study will analyze trends in cancer incidence, risk factors, treatment complications, and tumor progression, while also validating the significance of previously reported pathological prognostic factors.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with primary penile malignancies, including squamous cell carcinoma.
Not a fit: Patients with non-malignant conditions or those without a diagnosis of penile cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of penile cancer and improve treatment strategies for patients.
How similar studies have performed: Other studies focusing on cancer databases and patient outcomes have shown success in improving treatment approaches and understanding disease progression.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All diagnosed patients with a primary penile malignancy, including those with squamous carcinoma Exclusion Criteria: * No patient meeting the above criteria will be excluded
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Curtis A Pettaway — M.D. Anderson Cancer Center
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.